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Until just a few years ago, RNA interference (RNAi) technology was restricted to the research fields of plants,
C. elegans or Drosophila.The discovery of gene silencing by in vitro synthesized double-stranded RNA
(dsRNA) in mammalian cells has made the use of RNAi possible in nearly the entire life science kingdom.
DNA vectors delivering small interfering RNA (siRNA) directed by polymerase III or polymerase II promoters
to persistently inhibit target genes expression have extended this technology to study in vivo function of
these genes. Recently, RNAi has been used as a powerful tool in the functional analysis of nuclear receptors
and their coregulators.This short review will cover studies in this area.
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Introduction
RNA interference (RNAi) was first discovered in the
nematode worm Caenorhabditis elegans as a biological
response to double-stranded RNA (dsRNA), which
resulted in potent sequence-specific gene silencing [Fire
et al., 1998]. RNAi is an evolutionarily conserved process
involving a multi-step event, which generates small
interfering RNAs (siRNAs) of 21- to 23-nucleotide (nt) in
vivo by endogenous RNase III enzyme-Dicer.The
resulting siRNAs mediate destruction of their
complementary mRNA.The biology and mechanisms of
RNAi have been reviewed recently in detail [Fire et al.,
1998; Hannon, 2002].The breakthrough of RNAi study
is the discovery that dsRNA can selectively suppress
gene expression in cultured mammalian cells through
RNAi [Caplen et al., 2001; Elbashir et al., 2001a].The
short (<30 nt) synthetic interfering RNA duplexes are
successfully used to induce sequence-specific gene
silencing yet evade the host interferon response which
usually is activated by dsRNA longer than 30nt [Baglioni
and Nilsen, 1983;Williams, 1997]. Based on the
biochemical analysis of siRNA in Drosophila [Elbashir et
al., 2001b; Elbashir et al., 2001c; Zamore et al., 2000],
the structure of the in vitro synthesized siRNA is found
to be important to achieve effective gene inhibition
[Elbashir et al., 2001a]. SiRNAs with 3′ overhangs of two
uridines have been found to be more efficient in cultured
mammalian cells [Elbashir et al., 2001c]. At the moment,
there is no criterion to predict the ideal target sequence
of an siRNA. Although many of the siRNAs reported to
date are designed to target coding sequences, especially
the amino terminus 100-200 bases away from AUG [Sui
et al., 2002], successful gene silencing has been reported
for siRNA by targeting various sequences, including the
3′ untranslated region [McManus et al., 2002].Therefore,
the target sequences published in the literatures will
definitely provide a candidate pool for scientists who are
interested in the RNAi research.
A major drawback of using in vitro synthesized siRNAs
is its transient nature because mammalian cells lack the
mechanism to amplify siRNA-mediated silencing observed
in C. elegans and Drosophila [Hannon, 2002]. Gene
expression was only suppressed for no more than one
week. In the beginning of 2002, DNA vectors expressing
siRNAs directed by RNA polymerase III promoters were
made by several groups [Brummelkamp et al., 2002;
Paddison et al., 2002; Sui et al., 2002].These expression
vectors mediate the production of siRNAs from transcripts
containing a stem and loop structure-short hairpin RNA
(shRNA), which will lead to the continued expression of
siRNAs in the cells with a persistent and specific
knock-down of the target genes.This improved
expression system paves the way for long-term
loss-of-function studies.
However, the Polymerase III promoter is active in all
tissues and cannot be used to generate the tissue-specific
knock-down. Just recently, a new vector expressing long
ds-RNA from the Polymerase II promoter has been
developed to knock-down the target gene [Shinagawa
and Ishii, 2003].The ds-RNA transcribed from this vector
lacking 5′-cap structure and 3′-poly(A) tail, which facilitate
its exportation to cytoplasm, can silence target gene
without producing the interferon response.Transgenic
mice embryos expressing long ds-RNA for the
transcriptional co-repressor Ski from this vector exhibited
similar phenotypes to those of Ski-knock-out embryos.
Therefore, with this polymerase II expression vector, one
can efficiently knock down the expression of any gene in
animal in a tissue-specific manner without the host
interferon response.
RNAi for nuclear receptors and
coregulators
RNA interference with synthesized dsRNA or
vector-based siRNAs has endowed research with a whole
set of tools that facilitate genetic studies of many fields,
including the recent application of RNAi approaches in
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Review  Nuclear Receptor Signaling  |  The Open Access Journal of the Nuclear Receptor Signaling AtlasTable 1. siRNA targeting sequences of nuclear receptors and co-regulators  Abbreviations: FXR, Farnesoid X receptor; AR, Androgen Receptor;
SRC-1/2/3, Steroid Receptor Coactivator-1/2/3; NCoR, Nuclear Receptor Co-Repressor; SMRT, Silencing Mediator for Retinoid and Thyroid hormone
receptor; HDAC3, Histone Deacetylase 3;TBL1, Transducin β-Like protein 1;TBLR1, Transducin β-Like protein 1-Related protein; ERRα, Estrogen
Related Receptor α; ARA55, AR-associated protein 55; ARA70, AR-associated protein 70. * Ho-Geun Yoon and Jiemin Wong, personal communication.
** Haijun Zhou unpublished results
functional analysis of nuclear receptors and their
co-regulators. Since last year, RNAi has been introduced
to silence the expression of nuclear receptors and their
co-regulators in transient transfection assays (see Table
1 for details). FXR [Plass et al., 2002] and AR [Wright et
al., 2003] are the only published examples of nuclear
receptor superfamily which have been successfully
inhibited with synthetic siRNA. For the nuclear receptor
co-regulators, RNAi has been more widely used. By
introduction of synthetic siRNA, co-activators SRCs [Li
et al., 2003; Shang and Brown, 2002; Zhou et al., 2003]
and p300 [Debes et al., 2002] and co-repressors NcoR
and SMRT [Yoon et al., 2003] have been shown to be
inhibited efficiently. DNA vector based RNAi has been
demonstrated by several groups to knock down ERR α
[Schreiber et al., 2003] and the AR coactivators ARA55
[Rahman et al., 2003a] and ARA70 [Rahman et al.,
2003b]. Usually, the change of target gene expression is
detected by western analysis. In the case of FXR and
ERR α , RNA levels were determined [Plass et al., 2002;
Schreiber et al., 2003], while immunocytochemistry was
used to detect p300 after silencing by siRNA [Debes et
al., 2002].
Comparison of RNAi with other
techniques
Distinct from the antisense oligodeoxynucleotides
(asODN) and dominant negative forms, which mediate
RNaseH cleavage and functional interference
respectively, RNAi leads to target gene mRNA
degradation through the RNAase III machinery resulting
in the knock-down of protein expression, thereby affecting
the functions of nuclear receptors and coregulators.
Although RNAi technology has not been applied in any
in vivo system of nuclear receptors or coregulators, RNAi
induced effects in in vitro studies are comparable or better
than those produced by antisense oligodeoxynucleotides
[Cavarretta et al., 2002] or dominant negative form
[Rahman et al., 2003a; Rahman et al., 2003b]. In these
studies, asODN to SRC-1 reduced SRC-1 protein level
by 78% at best. In contrast, RNAi to SRC-1 is able to
reduce 80%-90% of its protein level. In addition, ARA55
and ARA70 knocking-down with DNA vector-based RNAi,
reduced the expression of AR target gene, PSA, to a
similar extent as that reduced by ARA55 and ARA70
dominant negative mutants. For the reporter assay, RNAi
knocking-down of ARA55 and ARA70 exerted a greater
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by dominant negative forms of ARA55 and ARA70. In
general, the effectiveness in most cases (listed in Table
1) is dramatic and has greatly helped the functional
analysis of these proteins.
Conclusion
There is no golden principle to predict the length of
sustaining time of RNAi inhibition, because each protein
has its own turnover time. Normally, the transient effect
of siRNA inhibition lasts less than one week. Multiple
transfections may be needed to extend its effect to a
longer time. Otherwise, vector-based RNAi either by
polymerase II or III is required to archive permanent
knock-down of target gene expression.The length of
targeting sequences range from 19nt to 21 nt, which
guarantee the sequence specificity, without generating
interferon response and mimic the product length of Dicer.
Usually, the effective sequence is chosen from several
candidates; therefore, the targeting sequences listed here
will be very helpful for the functional analysis of nuclear
receptors and co-regulators. Although RNAi technology
has not been used as widely as it can be in the nuclear
receptor field, we believe the importance and
effectiveness of this technology will be increasingly used
for functional analysis of nuclear receptor and coregulator
function for the years to come.
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